S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
NYSE:PRGO

Perrigo (PRGO) Stock Forecast, Price & News

$38.57
+1.22 (+3.27%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$37.76
$38.90
50-Day Range
$32.20
$38.57
52-Week Range
$31.32
$50.90
Volume
2.16 million shs
Average Volume
1.57 million shs
Market Capitalization
$5.19 billion
P/E Ratio
N/A
Dividend Yield
2.78%
Beta
1.01
30 days | 90 days | 365 days | Advanced Chart
Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

Perrigo logo

About Perrigo

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
71429010
Employees
9,900
Year Founded
1887

Sales & Book Value

Annual Sales
$4.14 billion
Cash Flow
$4.60 per share
Book Value
$38.51 per share

Profitability

Net Income
$-68.90 million
Pretax Margin
5.44%

Debt

Price-To-Earnings

Miscellaneous

Free Float
133,466,000
Market Cap
$5.19 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 3/17 Dividend
2/25/2022
Dividend Payable
3/17/2022
Last Earnings
5/11/2022
Today
5/18/2022
Ex-Dividend for 6/21 Dividend
6/02/2022
Dividend Payable
6/21/2022
Next Earnings (Estimated)
8/10/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.11 out of 5 stars

Medical Sector

9th out of 1,426 stocks

Pharmaceutical Preparations Industry

1st out of 680 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -













Perrigo (NYSE:PRGO) Frequently Asked Questions

Is Perrigo a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Perrigo stock.
View analyst ratings for Perrigo
or view top-rated stocks.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for Perrigo
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) released its quarterly earnings results on Wednesday, May, 11th. The company reported $0.33 EPS for the quarter, missing analysts' consensus estimates of $0.42 by $0.09. Perrigo had a positive trailing twelve-month return on equity of 4.88% and a negative net margin of 2.07%. During the same quarter in the prior year, the company posted $0.50 EPS.
View Perrigo's earnings history
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, May 5th. Investors of record on Friday, June 3rd will be given a dividend of $0.26 per share on Tuesday, June 21st. This represents a $1.04 annualized dividend and a yield of 2.70%. The ex-dividend date is Thursday, June 2nd.
View Perrigo's dividend history
.

Is Perrigo a good dividend stock?

Perrigo pays an annual dividend of $1.04 per share and currently has a dividend yield of 2.78%.
View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY 2022 earnings guidance on Wednesday, May, 18th. The company provided earnings per share (EPS) guidance of $2.30-$2.40 for the period. The company issued revenue guidance of $4.49 billion-$4.53 billion, compared to the consensus revenue estimate of $4.49 billion.

What price target have analysts set for PRGO?

3 brokers have issued 1-year price targets for Perrigo's stock. Their forecasts range from $48.00 to $63.00. On average, they expect Perrigo's stock price to reach $55.33 in the next year. This suggests a possible upside of 43.5% from the stock's current price.
View analysts' price targets for Perrigo
or view top-rated stocks among Wall Street analysts.

Who are Perrigo's key executives?
Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 62, Pay $2.78M)
  • Mr. Raymond P. Silcock, CFO & Exec. VP (Age 71, Pay $1.2M) (LinkedIn Profile)
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 62, Pay $2.01M) (LinkedIn Profile)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Self-Care International (Age 60, Pay $1.18M) (LinkedIn Profile)
  • Mr. James E. Dillard III, Exec. VP & Pres of Consumer Self-Care Americas (Age 58, Pay $999.36k)
  • Mr. Ronald C. Janish, Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain (Age 56)
  • Mr. Shannon Hukill, Sr. Director of Technical Operations
  • Mr. Thomas M. Farrington, Chief Information Officer & Exec. VP (Age 65)
  • Mr. Bradley Joseph, VP of Global Investor Relations & Corp. Communications
  • Ms. Mary Reilly-Brest, Director of Global Organizational and Human Resource Devel.
What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo CEO Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among Perrigo's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.25%), BlackRock Inc. (9.00%), Dimensional Fund Advisors LP (3.21%), State Street Corp (3.17%), Cooke & Bieler LP (2.87%) and Coho Partners Ltd. (2.81%). Company insiders that own Perrigo stock include Bradley A Alford, Geoffrey M Parker, Raymond Silcock, Richard S Sorota, Rolf A Classon, Ronald Craig Janish, Svend Andersen, Theodore R Samuels II, Thomas Farrington and Todd W Kingma.
View institutional ownership trends for Perrigo
.

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management , Clal Insurance Enterprises Holdings Ltd, JPMorgan Chase & Co., Citigroup Inc., Menora Mivtachim Holdings LTD., Connor Clark & Lunn Investment Management Ltd., TD Asset Management Inc., and American Century Companies Inc.. Company insiders that have sold Perrigo company stock in the last year include Ronald Craig Janish, and Thomas Farrington.
View insider buying and selling activity for Perrigo
or view top insider-selling stocks.

Which major investors are buying Perrigo stock?

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Coho Partners Ltd., Thompson Siegel & Walmsley LLC, Dimensional Fund Advisors LP, Pendal Group Ltd, DAVENPORT & Co LLC, Arrowstreet Capital Limited Partnership, and Edmond DE Rothschild Holding S.A.. Company insiders that have bought Perrigo stock in the last two years include Bradley A Alford, Geoffrey M Parker, Raymond Silcock, Richard S Sorota, Rolf A Classon, Svend Andersen, Theodore R Samuels II, and Todd W Kingma.
View insider buying and selling activity for Perrigo
or or view top insider-buying stocks.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $38.57.

How much money does Perrigo make?

Perrigo has a market capitalization of $5.19 billion and generates $4.14 billion in revenue each year. The company earns $-68.90 million in net income (profit) each year or ($0.65) on an earnings per share basis.

How many employees does Perrigo have?

Perrigo employs 9,900 workers across the globe.

When was Perrigo founded?

Perrigo was founded in 1887.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at (531) 709-4000, via email at [email protected], or via fax at 269-673-9128.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.